Two first-in-class migraine drugs, the first generic version of NuvaRing®, and 7 more fourth quarter FDA-approved drugs for primary care.
The FDA has approved the first oral CGRP receptor antagonist in pill form for the acute treatment of migraine with or without aura in adults.
ICYMI: Get a quick look at 12 of the many drugs FDA-approved in 2019 for conditions commonly seen in primary care.
When a patient presents to their primary care physician with a headache, it's not always diagnosed as the migraine it is. These 6 tips from a neurologist can help.
Five migraine management essentials for PCPs and headache patients are summarized with the mnemonic SEEDS.
"Typical aura without headache" is a relatively rare headache diagnosis and not easy to make. Three leading headache specialists offer guidance on how to recognize and treat.
Lasmitidan is the first 5-HT1F receptor agonist to receive FDA approval and was found superior to placebo for reduction of migraine pain and most bothersome symptom at 2 hours.
Children, tweens, and adolescents with migraine can use Migraine Trainer to log and share details that will help physicians individualize care in this vulnerable population.
Throbbing occipital headache x2 wks; abrupt onset, no history. Reason for alarm? Neurologist Peter McAllister, MD, suggests you SNOOP first.
What's your caffeine IQ? Test your knowledge on the latest caffeine research from its effect on cardiovascular disease to liver cancer with this brief quiz.